NAGE FY 2012 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$391M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+43.1% YoY

Gross Profit

$2M19.6% margin

Operating Income

-$12M-100.2% margin

Net Income

-$12M-100.4% margin

EPS (Diluted)

$-0.36

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$9M

Total Liabilities

$5M

Stockholders' Equity

$4M

Cash & Equivalents

$520,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$8M	+43.1%
Gross Profit	$2M	$2M	-7.9%
Operating Income	-$12M	-$8M	-48.0%
Net Income	-$12M	-$8M	-47.7%